INBX
Price
$13.33
Change
-$0.77 (-5.46%)
Updated
Apr 3 closing price
Capitalization
204.11M
54 days until earnings call
VCYT
Price
$27.97
Change
-$0.50 (-1.76%)
Updated
Apr 4, 11:37 AM (EDT)
Capitalization
1.66B
39 days until earnings call
Ad is loading...

INBX vs VCYT

Header iconINBX vs VCYT Comparison
Open Charts INBX vs VCYTBanner chart's image
Inhibrx Biosciences
Price$13.33
Change-$0.77 (-5.46%)
Volume$220.45K
Capitalization204.11M
Veracyte
Price$27.97
Change-$0.50 (-1.76%)
Volume$3.57K
Capitalization1.66B
INBX vs VCYT Comparison Chart
Loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. VCYT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a StrongBuy and VCYT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (INBX: $13.33 vs. VCYT: $28.47)
Brand notoriety: INBX and VCYT are both not notable
INBX represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INBX: 220% vs. VCYT: 92%
Market capitalization -- INBX: $204.11M vs. VCYT: $1.66B
INBX [@Biotechnology] is valued at $204.11M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 2 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 2 green, 3 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • INBX’s TA Score: 5 bullish, 3 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INBX is a better buy in the short-term than VCYT.

Price Growth

INBX (@Biotechnology) experienced а -6.91% price change this week, while VCYT (@Medical Specialties) price change was -8.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.88%. For the same industry, the average monthly price growth was -2.40%, and the average quarterly price growth was -1.71%.

Reported Earning Dates

INBX is expected to report earnings on May 28, 2025.

VCYT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-5.88% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than INBX($204M). INBX YTD gains are higher at: -13.442 vs. VCYT (-28.106). INBX has higher annual earnings (EBITDA): 1.72B vs. VCYT (-49.41M). VCYT has more cash in the bank: 216M vs. INBX (196M). INBX has less debt than VCYT: INBX (1.84M) vs VCYT (12.6M). VCYT has higher revenues than INBX: VCYT (361M) vs INBX (1.57M).
INBXVCYTINBX / VCYT
Capitalization204M1.66B12%
EBITDA1.72B-49.41M-3,485%
Gain YTD-13.442-28.10648%
P/E Ratio0.12N/A-
Revenue1.57M361M0%
Total Cash196M216M91%
Total Debt1.84M12.6M15%
FUNDAMENTALS RATINGS
VCYT: Fundamental Ratings
VCYT
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INBXVCYT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VKSDX10.12N/A
N/A
Virtus KAR Small-Mid Cap Value A
CCERX26.26N/A
N/A
Columbia Large Cap Enhanced Core R
HGOSX58.91N/A
N/A
Hartford Growth Opportunities R4
ITGSX81.52N/A
N/A
VY® T. Rowe Price Growth Equity S
LGCVX16.56N/A
N/A
Lord Abbett Global Equity R5

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-5.46%
AXON - INBX
48%
Loosely correlated
-3.35%
AKESF - INBX
45%
Loosely correlated
-7.01%
SNTI - INBX
39%
Loosely correlated
-6.54%
RAPT - INBX
38%
Loosely correlated
-4.31%
VCYT - INBX
37%
Loosely correlated
-5.51%
More